⌘K

Omeros Corporation (OMER)

$3.93 -1.75% $-0.07 Healthcare

Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA); that is in Phase III clinical trial for immunoglobulin A nephropathy (IgAN) and atypical hemolytic uremic syndrome (aHUS); and Phase II clinical trial to treat COVID-19. Its clinical programs also consist of PPAR? (OMS405) that is in Phase II to treat opioid and nicotine addiction; PDE7 (OMS527), which is in Phase I trial for treating addiction and compulsive disorders, and movement disorders; and MASP-3 (OMS906) that is in Phase I trial for paroxysmal nocturnal hemoglobinuria (PNH) and other alternative pathway disorders. The company's preclinical programs comprise MASP-2-small-molecule inhibitors used for the treatment of aHUS, IgAN, HSCT-TMA, and age-related macular degeneration; longer-acting second generation antibody targeting MASP-2; and MASP-3-small-molecule inhibitors to treat PNH and other alternative pathway disorders. Its preclinical programs also include GPR174 Inhibitors and Chimeric Antigen Receptor (CAR) T-Cell and Adoptive T-Cell Therapies for various cancers; and G protein-coupled receptor targets for treating immunologic, immuno-oncologic, metabolic, CNS, cardiovascular, musculoskeletal, and other disorders. The company was incorporated in 1994 and is headquartered in Seattle, Washington.

Market cap

$227.73M

CEO

Dr. Gregory A. Demopulos M.D.

Full time employees

213.00

Headquarters

Seattle, WA

IPO Date

Oct 08, 2009

Price-to-earnings (PE) Ratio

-1.18

Earnings-per-share (EPS)

$-3.32

Cash ratio (TTM)

0.04

Current ratio (TTM)

3.41

Net profit margin (TTM)

-10,252.05%

PE ratio (TTM)

-1.66

PEG ratio (TTM)

1.32

Price-to-book ratio (TTM)

-1.86

Price-to-sales ratio (TTM)

169.68

Quick ratio (TTM)

3.41

Return on assets (TTM)

-39.30%

Return on equity (TTM)

238.51%

Similar stocks (19)

Cerevel Therapeutics Holdings, Inc.

CERE

$44.96 0.74% $0.33

Uptrend

Revolution Medicines, Inc.

RVMD

$44.06 0.66% $0.29

Uptrend

Avidity Biosciences, Inc.

RNA

$44.63 5.78% $2.44

Uptrend

Crinetics Pharmaceuticals, Inc.

CRNX

$52.77 -0.42% $-0.22

Uptrend

Amicus Therapeutics, Inc.

FOLD

$10.91 -2.59% $-0.29

Downtrend

Protagonist Therapeutics, Inc.

PTGX

$44.77 -0.31% $-0.14

Uptrend

Ligand Pharmaceuticals Incorporated

LGND

$103.68 -0.56% $-0.58

Uptrend

Akero Therapeutics, Inc.

AKRO

$26.96 1.20% $0.32

Uptrend

Mirum Pharmaceuticals, Inc.

MIRM

$37.90 -5.93% $-2.39

Neutral

Arcutis Biotherapeutics, Inc.

ARQT

$10.40 0.29% $0.03

Uptrend

Day One Biopharmaceuticals, Inc.

DAWN

$13.79 0.22% $0.03

Downtrend

Stoke Therapeutics, Inc.

STOK

$15.22 0.66% $0.10

Uptrend

ORIC Pharmaceuticals, Inc.

ORIC

$10.67 5.64% $0.57

Neutral

Lyell Immunopharma, Inc.

LYEL

$1.35 -2.88% $-0.04

Downtrend

Design Therapeutics, Inc.

DSGN

$5.64 -2.25% $-0.13

Uptrend

Biomea Fusion, Inc.

BMEA

$8.69 5.21% $0.43

Downtrend

Enanta Pharmaceuticals, Inc.

ENTA

$11.39 -2.23% $-0.26

Downtrend

Gossamer Bio, Inc.

GOSS

$0.91 1.38% $0.01

Downtrend

Passage Bio, Inc.

PASG

$0.70 -3.60% $-0.03

Downtrend

ETF Exposure (28)

Jacob Forward ETF

JFWD

4.11%

$10.60 0.23% $0.02

Uptrend

Invesco NASDAQ Future Gen 200 ETF

QQQS

0.562%

$27.02 -0.33% $-0.09

Uptrend

iShares Micro-Cap ETF

IWC

0.05965%

$123.83 0.30% $0.37

Uptrend

iShares Russell 2000 Value ETF

IWN

0.0112%

$167.32 0.13% $0.22

Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0.01%

$203.69 0.00% $0.00

Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.01%

$88.74 0.03% $0.03

Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0.01%

$147.48 0.05% $0.07

Uptrend

iShares Russell 2000 ETF

IWM

0.00875%

$219.45 0.02% $0.04

Uptrend

Schwab U.S. Small-Cap ETF

SCHA

0.006391089%

$50.99 0.04% $0.02

Uptrend

iShares Russell 2000 Growth ETF

IWO

0.00607%

$279.68 0.00% $0.00

Uptrend

ProShares Ultra Russell2000

UWM

0.0032804984692711113%

$42.29 -0.05% $-0.02

Uptrend

ProShares UltraPro Russell2000

URTY

0.0016163807817637212%

$51.08 0.10% $0.05

Uptrend

ProShares Hedge Replication ETF

HDG

0.0013791136448237354%

$50.00 0.40% $0.20

Uptrend

iShares Russell 3000 ETF

IWV

5.4e-4%

$320.03 -0.31% $-0.98

Uptrend

Schwab U.S. Broad Market ETF

SCHB

4.447561e-4%

$65.12 -0.23% $-0.15

Uptrend

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF

GSSC

$68.60 0.03% $0.02

Uptrend

iShares MSCI USA Small-Cap Multifactor ETF

SMLF

$65.42 0.05% $0.03

Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$49.43 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$49.42 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund

VBINX

$49.42 -0.26% $-0.13

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$96.13 -0.25% $-0.24

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$96.11 -0.25% $-0.24

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Russell 3000 Index Fund

VTHR

$248.45 -0.40% $-0.99

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$277.35 -0.25% $-0.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$179.34 0.03% $0.06

Uptrend

Neutral

Similar stocks (19)

Cerevel Therapeutics Holdings, Inc.

CERE

$44.96 0.74% $0.33

Uptrend

Revolution Medicines, Inc.

RVMD

$44.06 0.66% $0.29

Uptrend

Avidity Biosciences, Inc.

RNA

$44.63 5.78% $2.44

Uptrend

Crinetics Pharmaceuticals, Inc.

CRNX

$52.77 -0.42% $-0.22

Uptrend

Amicus Therapeutics, Inc.

FOLD

$10.91 -2.59% $-0.29

Downtrend

Protagonist Therapeutics, Inc.

PTGX

$44.77 -0.31% $-0.14

Uptrend

Ligand Pharmaceuticals Incorporated

LGND

$103.68 -0.56% $-0.58

Uptrend

Akero Therapeutics, Inc.

AKRO

$26.96 1.20% $0.32

Uptrend

Mirum Pharmaceuticals, Inc.

MIRM

$37.90 -5.93% $-2.39

Neutral

Arcutis Biotherapeutics, Inc.

ARQT

$10.40 0.29% $0.03

Uptrend

Day One Biopharmaceuticals, Inc.

DAWN

$13.79 0.22% $0.03

Downtrend

Stoke Therapeutics, Inc.

STOK

$15.22 0.66% $0.10

Uptrend

ORIC Pharmaceuticals, Inc.

ORIC

$10.67 5.64% $0.57

Neutral

Lyell Immunopharma, Inc.

LYEL

$1.35 -2.88% $-0.04

Downtrend

Design Therapeutics, Inc.

DSGN

$5.64 -2.25% $-0.13

Uptrend

Biomea Fusion, Inc.

BMEA

$8.69 5.21% $0.43

Downtrend

Enanta Pharmaceuticals, Inc.

ENTA

$11.39 -2.23% $-0.26

Downtrend

Gossamer Bio, Inc.

GOSS

$0.91 1.38% $0.01

Downtrend

Passage Bio, Inc.

PASG

$0.70 -3.60% $-0.03

Downtrend

ETF Exposure (28)

Jacob Forward ETF

JFWD

4.11%

$10.60 0.23% $0.02

Uptrend

Invesco NASDAQ Future Gen 200 ETF

QQQS

0.562%

$27.02 -0.33% $-0.09

Uptrend

iShares Micro-Cap ETF

IWC

0.05965%

$123.83 0.30% $0.37

Uptrend

iShares Russell 2000 Value ETF

IWN

0.0112%

$167.32 0.13% $0.22

Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0.01%

$203.69 0.00% $0.00

Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.01%

$88.74 0.03% $0.03

Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0.01%

$147.48 0.05% $0.07

Uptrend

iShares Russell 2000 ETF

IWM

0.00875%

$219.45 0.02% $0.04

Uptrend

Schwab U.S. Small-Cap ETF

SCHA

0.006391089%

$50.99 0.04% $0.02

Uptrend

iShares Russell 2000 Growth ETF

IWO

0.00607%

$279.68 0.00% $0.00

Uptrend

ProShares Ultra Russell2000

UWM

0.0032804984692711113%

$42.29 -0.05% $-0.02

Uptrend

ProShares UltraPro Russell2000

URTY

0.0016163807817637212%

$51.08 0.10% $0.05

Uptrend

ProShares Hedge Replication ETF

HDG

0.0013791136448237354%

$50.00 0.40% $0.20

Uptrend

iShares Russell 3000 ETF

IWV

5.4e-4%

$320.03 -0.31% $-0.98

Uptrend

Schwab U.S. Broad Market ETF

SCHB

4.447561e-4%

$65.12 -0.23% $-0.15

Uptrend

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF

GSSC

$68.60 0.03% $0.02

Uptrend

iShares MSCI USA Small-Cap Multifactor ETF

SMLF

$65.42 0.05% $0.03

Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$49.43 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$49.42 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund

VBINX

$49.42 -0.26% $-0.13

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$96.13 -0.25% $-0.24

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$96.11 -0.25% $-0.24

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Russell 3000 Index Fund

VTHR

$248.45 -0.40% $-0.99

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$277.35 -0.25% $-0.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$179.34 0.03% $0.06

Uptrend